Gene · 11140
Papers1,640
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,640
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling from RAS to RAF: The Molecules and Their Mechanisms. | Annu Rev Biochem | 2024 | 38316136 | PubTator, text mining | PubMed |
| Stress biology: Complexity and multifariousness in health and disease. | Cell Stress Chaperones | 2024 | 38311120 | PubTator, text mining | PubMed |
| Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer. | Nat Commun | 2024 | 38302471 | PubTator, text mining | PubMed |
| Heat shock protein 90: biological functions, diseases, and therapeutic targets. | MedComm (2020) | 2024 | 38283176 | PubTator, text mining | PubMed |
| Heat Shock Proteins and Breast Cancer. | Int J Mol Sci | 2024 | 38255948 | PubTator, text mining | PubMed |
| Single-cell analysis of the cellular landscape of vulvar melanoma provides new insight for immunotherapy administration. | BMC Cancer | 2024 | 38233802 | PubTator, text mining | PubMed |
| Cochaperones convey the energy of ATP hydrolysis for directional action of Hsp90. | Nat Commun | 2024 | 38233436 | PubTator, text mining | PubMed |
| Rational design of peptide inhibitors targeting HSP90-CDC37 protein-protein interaction. | Future Med Chem | 2024 | 38189168 | PubTator, text mining | PubMed |
| Induced protein degradation for therapeutics: past, present, and future. | J Clin Invest | 2024 | 38165043 | PubTator, text mining | PubMed |
| Proteomic Analysis Revealed the Potential Role of MAGE-D2 in the Therapeutic Targeting of Triple-Negative Breast Cancer. | Mol Cell Proteomics | 2024 | 38128647 | PubTator, text mining | PubMed |
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. | Int Wound J | 2024 | 37697692 | PubTator, text mining | PubMed |
| Ginsenoside Rg5 enhances the radiosensitivity of lung adenocarcinoma via reducing HSP90-CDC37 interaction and promoting client protein degradation. | J Pharm Anal | 2023 | 38174116 | PubTator, text mining | PubMed |
| An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases. | Int J Mol Sci | 2023 | 38139428 | PubTator, text mining | PubMed |
| Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. | Mol Cancer | 2023 | 38111008 | PubTator, text mining | PubMed |
| A Fluorescence-Based Sensor for Calibrated Measurement of Protein Kinase Stability in Live Cells. | bioRxiv | 2023 | 38106090 | PubTator, text mining | PubMed |
| Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells. | Cell Death Dis | 2023 | 38057328 | PubTator, text mining | PubMed |
| Mechanism Research and Application for Ginsenosides in the Treatment of Hepatocellular Carcinoma. | Biomed Res Int | 2023 | 38027042 | PubTator, text mining | PubMed |
| Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA. | Clin Med Insights Endocrinol Diabetes | 2023 | 38023736 | PubTator, text mining | PubMed |
Comparative Transcriptomic Analyses Propose the Molecular Regulatory Mechanisms Underlying 1,8-Cineole from Cinnamomum kanehirae Hay and Promote the Asexual Sporulation of Antrodia cinnamomea in Submerged Fermentation. | Molecules | 2023 | 38005233 | PubTator, text mining | PubMed |
| Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson's Disease. | Int J Mol Sci | 2023 | 38003423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11140/papers?page=4